No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Adipocytokine signaling pathway 2 genes, 4 drugs (DrugBank) and 14 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
1件: PPARA |
D01366 |
Bezafibrate |
5件: 20, 93, 94, 160, 316 |
D11208 |
Elafibranor |
1件: 93 |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
2 | African trypanosomiasis 2 genes, 1 drug (DrugBank) and 16 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
3 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
4 | Allograft rejection 4 genes, 2 drugs (DrugBank) and 28 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
5 | Amoebiasis 2 genes, 1 drug (DrugBank) and 16 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
6 | AMPK signaling pathway 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
D07474 |
7 | Antifolate resistance 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
8 | Autoimmune thyroid disease 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
9 | Bile secretion 2 genes, 3 drugs (DrugBank) and 26 diseases shown |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
D07474 |
1件: NR1H4 |
D09360 |
Obeticholic acid |
3件: 93, 265, 296 |
D00734 |
Ursodeoxycholic acid |
12件: 6, 8, 20, 67, 84, 93, 94, 95, 96, 97, 234, 299 |
10 | Breast cancer 1 gene, 1 drug (DrugBank) and 7 diseases shown |
1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
11 | C-type lectin receptor signaling pathway 3 genes, 1 drug (DrugBank) and 16 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
12 | cAMP signaling pathway 1 gene, 3 drugs (DrugBank) and 8 diseases shown |
1件: PPARA |
D01366 |
Bezafibrate |
5件: 20, 93, 94, 160, 316 |
D11208 |
Elafibranor |
1件: 93 |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
13 | Cell adhesion molecules (CAMs) 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
14 | Chagas disease (American trypanosomiasis) 3 genes, 2 drugs (DrugBank) and 16 diseases shown |
1件: ACE |
D00623 |
Moexipril |
1件: 93 |
D08225 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
15 | Chemokine signaling pathway 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
16 | Cholinergic synapse 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
17 | Cytokine-cytokine receptor interaction 4 genes, 2 drugs (DrugBank) and 19 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
18 | EGFR tyrosine kinase inhibitor resistance 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
19 | Epstein-Barr virus infection 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
20 | Fat digestion and absorption 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: NPC1L1 |
D01966 |
Ezetimibe |
4件: 49, 79, 93, 260 |
21 | Folate biosynthesis 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
22 | Gap junction 9 genes, 1 drug (DrugBank) and 5 diseases shown |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00570 |
Colchicine |
5件: 2, 42, 56, 93, 266 |
23 | Glucagon signaling pathway 1 gene, 3 drugs (DrugBank) and 8 diseases shown |
1件: PPARA |
D01366 |
Bezafibrate |
5件: 20, 93, 94, 160, 316 |
D11208 |
Elafibranor |
1件: 93 |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
24 | Graft-versus-host disease 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
25 | Growth hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
26 | Hematopoietic cell lineage 1 gene, 1 drug (DrugBank) and 42 diseases shown |
1件: MS4A1 |
D02994 |
Rituximab |
42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
27 | Hepatitis B 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
28 | Hepatitis C 2 genes, 4 drugs (DrugBank) and 14 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
1件: PPARA |
D01366 |
Bezafibrate |
5件: 20, 93, 94, 160, 316 |
D11208 |
Elafibranor |
1件: 93 |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
29 | Herpes simplex virus 1 infection 4 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
30 | Human cytomegalovirus infection 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
31 | Human papillomavirus infection 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
32 | Human T-cell leukemia virus 1 infection 2 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: FDPS |
D00942 |
Risedronic acid |
7件: 46, 66, 93, 95, 96, 113, 274 |
D03234 |
D08484 |
D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
D06378 |
D06379 |
D08689 |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
33 | Hypertrophic cardiomyopathy (HCM) 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: ACE |
D00623 |
Moexipril |
1件: 93 |
D08225 |
34 | Inflammatory bowel disease (IBD) 3 genes, 1 drug (DrugBank) and 16 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
35 | Influenza A 5 genes, 4 drugs (DrugBank) and 26 diseases shown |
1件: FDPS |
D00942 |
Risedronic acid |
7件: 46, 66, 93, 95, 96, 113, 274 |
D03234 |
D08484 |
D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
D06378 |
D06379 |
D08689 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
36 | Insulin resistance 1 gene, 3 drugs (DrugBank) and 8 diseases shown |
1件: PPARA |
D01366 |
Bezafibrate |
5件: 20, 93, 94, 160, 316 |
D11208 |
Elafibranor |
1件: 93 |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
37 | Intestinal immune network for IgA production 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
38 | JAK-STAT signaling pathway 5 genes, 2 drugs (DrugBank) and 19 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
39 | Kaposi sarcoma-associated herpesvirus infection 3 genes, 2 drugs (DrugBank) and 26 diseases shown |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
40 | Legionellosis 2 genes, 1 drug (DrugBank) and 16 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
41 | Leishmaniasis 4 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
42 | Malaria 1 gene, 1 drug (DrugBank) and 16 diseases shown |
1件: IL12A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
43 | Measles 3 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
44 | Metabolic pathways 4 genes, 4 drugs (DrugBank) and 48 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
1件: FDPS |
D00942 |
Risedronic acid |
7件: 46, 66, 93, 95, 96, 113, 274 |
D03234 |
D08484 |
D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
D06378 |
D06379 |
D08689 |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
D07474 |
45 | Necroptosis 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
46 | Neuroactive ligand-receptor interaction 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: NR3C1 |
D00246 |
Budesonide |
10件: 66, 85, 93, 94, 95, 96, 97, 98, 228, 299 |
47 | NF-kappa B signaling pathway 1 gene, 1 drug (DrugBank) and 7 diseases shown |
1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
48 | NOD-like receptor signaling pathway 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
49 | Non-alcoholic fatty liver disease (NAFLD) 1 gene, 3 drugs (DrugBank) and 8 diseases shown |
1件: PPARA |
D01366 |
Bezafibrate |
5件: 20, 93, 94, 160, 316 |
D11208 |
Elafibranor |
1件: 93 |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
50 | One carbon pool by folate 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
51 | Osteoclast differentiation 2 genes, 2 drugs (DrugBank) and 12 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
52 | Pancreatic cancer 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
53 | Parathyroid hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank) and 7 diseases shown |
1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
54 | Pathogenic Escherichia coli infection 9 genes, 1 drug (DrugBank) and 5 diseases shown |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00570 |
Colchicine |
5件: 2, 42, 56, 93, 266 |
55 | Pathways in cancer 5 genes, 2 drugs (DrugBank) and 19 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
56 | PD-L1 expression and PD-1 checkpoint pathway in cancer 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
57 | Pertussis 3 genes, 1 drug (DrugBank) and 16 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
58 | Phagosome 9 genes, 1 drug (DrugBank) and 5 diseases shown |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00570 |
Colchicine |
5件: 2, 42, 56, 93, 266 |
59 | PI3K-Akt signaling pathway 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
60 | PPAR signaling pathway 1 gene, 3 drugs (DrugBank) and 8 diseases shown |
1件: PPARA |
D01366 |
Bezafibrate |
5件: 20, 93, 94, 160, 316 |
D11208 |
Elafibranor |
1件: 93 |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
61 | Prolactin signaling pathway 2 genes, 2 drugs (DrugBank) and 12 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
62 | Proteoglycans in cancer 1 gene, 1 drug (DrugBank) and 16 diseases shown |
1件: IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
63 | Renin secretion 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: ACE |
D00623 |
Moexipril |
1件: 93 |
D08225 |
64 | Renin-angiotensin system 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: ACE |
D00623 |
Moexipril |
1件: 93 |
D08225 |
65 | Rheumatoid arthritis 4 genes, 3 drugs (DrugBank) and 31 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
66 | RIG-I-like receptor signaling pathway 2 genes, 1 drug (DrugBank) and 16 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
67 | Signaling pathways regulating pluripotency of stem cells 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
68 | Systemic lupus erythematosus 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
69 | Terpenoid backbone biosynthesis 2 genes, 3 drugs (DrugBank) and 24 diseases shown |
1件: FDPS |
D00942 |
Risedronic acid |
7件: 46, 66, 93, 95, 96, 113, 274 |
D03234 |
D08484 |
D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
D06378 |
D06379 |
D08689 |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
D07474 |
70 | Th1 and Th2 cell differentiation 4 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
71 | Th17 cell differentiation 3 genes, 2 drugs (DrugBank) and 19 diseases shown |
1件: IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
72 | Toll-like receptor signaling pathway 4 genes, 2 drugs (DrugBank) and 28 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
73 | Toxoplasmosis 4 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
74 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank) and 24 diseases shown |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
75 | Tuberculosis 5 genes, 2 drugs (DrugBank) and 19 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
76 | Type I diabetes mellitus 4 genes, 2 drugs (DrugBank) and 28 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
77 | Viral carcinogenesis 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
78 | Viral myocarditis 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |